Mortality associated with influenza and respiratory syncytial virus in the United States

Journal of the American Medical Association

Volumn 289, Issue 2, 2003, Pages 179-186

  Thompson, William W ^a,c   Shay, David K ^b,c   Weintraub, Eric ^a,c   Cox, Nancy ^a   Anderson, Larry J ^b   Fukuda, Keiji ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Immunization Safety Branch   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFANT; INFECTION PREVENTION; INFLUENZA; INFLUENZA VIRUS; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MORTALITY; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; RISK FACTOR; SEASON; STATISTICAL MODEL; UNITED STATES; VIRUS INFECTION; VIRUS TYPING;

EID: 0037425564     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.2.179     Document Type: Article

References (46)

1. Simonsen L, Clarke MJ, Williamson GD, et al. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health. 1997;87:1944-1950.
2. Simonsen L, Clarke MJ, Schonberger LB, et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis. 1998;178:53-60.
3. Bridges CB, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MM WR Recomm Rep. 2002;51(RR-3):1-31.
4. Bisno AL, Griffin JP, Van Epps KA, et al. Pneumonia and Hong Kong influenza: a prospective study of the 1968-1969 epidemic. Am J Med Sci. 1971;261:251-263.
5. Douglas RG Jr. Influenza: the disease and its complications. Hosp Pract. 1976;11:43-50.
6. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med. 1999;130:397-403.
7. Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med. 1998;158:1769-1776.
8. Griffin MR, Coffey CS, Neuzil KM, et al. Winter viruses: influenza- and respiratory syncytial virus-related morbidity in chronic lung disease. Arch Intern Med. 2002;162:1229-1236.
9. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. Am Rev Respir Dis. 1987;136:550-555.
10. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342:232-239.
11. Anderson LJ, Parker RA, Strikas RL. Association between respiratory syncytial virus outbreaks and lower respiratory tract deaths of infants and young children. J Infect Dis. 1990;161:640-646.
12. Han LL, Alexander JP, Anderson LJ. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J Infect Dis. 1999;179:25-30.
13. Nicholson KG. Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990. Epidemiol infect. 1996;116:51-63.
14. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet. 2001;358:1410-1416.
15. Falsey AR, McCann RM, Hall WJ, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc. 1995;43:30-36.
16. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13:371-384.
17. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis. 1996;174:456-462.
18. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 1999;160:791-795.
19. Fleming DM, Cross KW. Respiratory syncytial virus or influenza? Lancet. 1993;342:1507-1510.
20. Brammer TL, Izurieta HS, Fukuda K, et al. Surveillance for influenza - United States, 1994-95, 1995-96, and 1996-97 seasons. MMWR Morb Mortal Wkly Rep. 2000;49:13-28.
21. Centers for Disease Control and Prevention. Update: respiratory syncytial virus activity - United States, 1999-2000 season. MMWR Morb Mortal Wkly Rep. 2000;49:1091-1093.
22. Vital Statistics Mortality Data, Multiple Cause Detail, 1972-1999 [package insert]. Hyattsville, Md: National Center for Health Statistics; 1999.
23. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Based on Recommendations of the Ninth Revision Conference, 1975. Geneva, Switzerland: World Health Organization; 1977.
24. World Health Organization. Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, Based on Recommendations of the Tenth Revision Conference, 1992. Geneva, Switzerland: World Health Organization; 1992.
25. Hetzel AM. History and Organization of the Vital Statistics System. Hyattsville, Md: National Center for Health Statistics; 1997.
26. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49(2):1-32.
27. US Bureau of the Census. Intercensal Estimates of the Population by Age, Sex, and Race. Washington, DC: US Bureau of the Census; 1990.
28. Farr W. Vital Statistics: A Memorial Volume of Selections From the Reports and Writing With a Biographical Sketch. London, England: Office of the Sanitary Institute, HSMO; 1885.
29. Centers for Disease Control and Prevention. Health, United States, 1999: With Health and Aging Chartbooks. Washington, DC: US Dept of Health and Human Services; 1999. DHHS publication (PHS) 99-1232.
30. Christenson B, Lundbergh P, Hedlund J, Ortqvist A. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet. 2001;357:1008-1011.
31. Barker WH, Borisute H, Cox C. A study of the impact of influenza on the functional status of frail older people. Arch Intern Med. 1998;158:645-650.
32. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans. J Infect Dis. 2001;184:665-670.
33. Glaser CA, Gilliam S, Thompson WW, et al. Medical care capacity for influenza outbreaks, Los Angeles. Emerg Infect Dis. 2002;8:569-574.
34. Nichol KL, Margolis KL, Wouremna J, von Sternberg T. Effectiveness of influenza vaccine in the elderly. Gerontology. 1996;42:274-279.
35. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784.
36. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527.
37. Katz JM, Lu X, Todd CW, Newman MJ. A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice. Vaccine. 2000;18:2177-2187.
38. Treanor JJ, Mattison HR, Dumyati G, et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Ann Intern Med. 1992;117:625-633.
39. Reichert TA, Sugaya N, Fedson DS, et al. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med. 2001;344:889-896.
40. Longini IM, Halloran ME, Nizam A, et al. Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control. Vaccine. 2000;18:1902-1909.
41. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA. 1999;282:1440-1446.
42. Shay DK, Holman RC, Roosevelt GE, et al. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J Infect Dis. 2001;183:16-22.
43. Falsey AR, Walsh EE, Looney RJ, et al. Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults. J Med Virol. 1999;59:221-226.
44. Wright PF, Karron RA, Belshe RB, et al. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis. 2000;182:1331-1342.
45. Teng MN, Whitehead SS, Bermingham A, et al. Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J Virol. 2000;74:9317-9321.
46. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. Vaccine. 1996;14:1214-1218.